<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(7)</volume><submitter>Wu J</submitter><journal>Annals of translational medicine</journal><pagination>425</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9073773</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?</pubmed_title><pmcid>PMC9073773</pmcid><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Zhao A</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Chen C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?</name><description/><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-27T03:12:25.227Z</modification><creation>2025-04-06T18:48:57.062Z</creation></dates><accession>S-EPMC9073773</accession><cross_references><pubmed>35530946</pubmed><doi>10.21037/atm-21-7018</doi></cross_references></HashMap>